Breaking News: CAPNOS® Secures $150K in Pre-Seed Funding to Revolutionize Vaping Cessation

CAPNOS® is thrilled to announce the successful closure of a $150,000 funding round aimed at enhancing our mission to prevent lung disease and save lives. With an increasing number of individuals struggling with vaping addiction, we've created the CAPNOS® Zero, a groundbreaking behavioral aid designed to tackle the complex challenges associated with quitting. Unlike traditional cessation methods, the CAPNOS® Zero acts as a pressurized air inhaler that effectively addresses the oral fixations and hand-to-mouth habits often associated with vaping. This innovative device not only provides a satisfying sensory experience but also helps users break free from the behavioral cycles that contribute to dependence. The newly raised capital will be integral in expanding our research and development efforts, optimizing production processes, and ramping up our marketing initiatives to reach more individuals in need. Our goal is to empower those looking to quit vaping and provide support to their loved ones by raising awareness about the CAPNOS® Zero and its benefits. As we look to the future, we are committed to fostering a healthier society by providing effective solutions to combat the vaping epidemic. For anyone struggling with vaping addiction or who knows someone facing this issue, we encourage you to follow us for updates and share the word about CAPNOS®! Together, we can work towards a smoke-free generation and make a meaningful impact in the lives of many.